Light Mode
$4.19 ↑ +0.00 (+0.00%) Trading Up from the previous close of $4.19, $0.07 below the day’s high of $4.26
-6.61 (-61.20%) / 6M
Momentum, market sentiment, and recent alerts
ARTV reads poor: price sits below both the 20- and 200-day averages, the 12-month move is +0.5%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.